MiMedx Group, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
MiMedx Group, Inc. (MDXG) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $3.69 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-25
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $3.69M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.89M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.79M.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.77M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $3.69M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.89M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $1.79M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $1.77M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $3.01M 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.91M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.88M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $1.88M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $764.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $759.00K 10-Q · filed 2023-10-30 |
| 2023-06-30 | $759.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $759.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $756.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $698.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $696.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $684.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $679.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $695.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $694.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $692.00K 10-Q · filed 2021-04-28 |
| 2020-12-31 | $793.00K 10-K · filed 2021-03-08 |
| 2019-12-31 | $985.00K 10-K · filed 2020-07-06 |
| 2018-12-31 | $976.00K 10-K · filed 2020-03-17 |
| 2016-12-31 | $2.03M 10-K · filed 2017-03-01 |
| 2015-12-31 | $936.00K 10-K · filed 2017-02-22 |
| 2014-12-31 | $929.00K 10-K · filed 2015-03-13 |
| 2013-12-31 | $923.93K 10-K · filed 2014-03-04 |
| 2013-09-30 | $1.05M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.07M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $1.05M 10-Q · filed 2013-05-10 |
| 2012-09-30 | $262.60K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $667.96K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |